|
Perspective on cancelling out of meetings (such as NKF)
|
12
|
Resverlogix Corp.
|
Mar 25, 2020 11:50AM
|
|
Re: Cytokine storm hypothesis takes a hit with the latest IL-6 targeted therapies
|
12
|
Resverlogix Corp.
|
Apr 27, 2020 02:39PM
|
|
Re: New-Report of exempt distribution
|
10
|
Resverlogix Corp.
|
Jan 05, 2021 05:40PM
|
|
Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study
|
10
|
Resverlogix Corp.
|
Jun 22, 2020 10:42PM
|
|
Re: ACC/WCC Virtual 2020
|
10
|
Resverlogix Corp.
|
Mar 29, 2020 08:44AM
|
|
Re: Breakthrough Designation
|
10
|
Resverlogix Corp.
|
May 28, 2020 07:36AM
|
|
Re: Management performance
|
10
|
Resverlogix Corp.
|
Apr 27, 2021 12:49PM
|
|
RVX 208 and the cytokine storm syndrome
|
10
|
Resverlogix Corp.
|
Apr 19, 2020 09:56AM
|
|
The more, the merrier
|
9
|
Resverlogix Corp.
|
Jun 22, 2020 01:20PM
|
|
Re: National Kidney Foundation -Abstract: BOM
|
9
|
Resverlogix Corp.
|
Mar 30, 2020 04:00PM
|
|
The problem...as I see it
|
9
|
Resverlogix Corp.
|
Oct 16, 2020 12:40PM
|
|
Re: "Stem Cells and Synthetic Biology” Featuring Dr. Krishanu Saha
|
9
|
Resverlogix Corp.
|
Apr 20, 2021 09:11PM
|
|
Re: The cardiac pre-print now published....in Cell!
|
9
|
Resverlogix Corp.
|
Mar 16, 2021 06:39PM
|
|
Opportunity Cost
|
9
|
Resverlogix Corp.
|
Feb 02, 2021 09:23AM
|
|
Re: Nature Article on the role of Endothelial Cells in COVID 19 - more stuff
|
9
|
Resverlogix Corp.
|
May 31, 2020 04:35PM
|
|
News! - COVID 19 pre-clinical and clinical research trials
|
9
|
Resverlogix Corp.
|
Jun 01, 2020 08:38AM
|
|
Nature Article on the role of Endothelial Cells in COVID 19
|
9
|
Resverlogix Corp.
|
May 21, 2020 08:41AM
|
|
Re: Tweet from Prof Kausik Ray
|
9
|
Resverlogix Corp.
|
Jun 01, 2020 10:45AM
|
|
Re: Todays presentation - Archman and paladin
|
9
|
Resverlogix Corp.
|
May 12, 2021 02:38PM
|
|
NAFLD is going to get much worse
|
8
|
Resverlogix Corp.
|
Jun 25, 2020 10:59AM
|
